Healthcare costs of atypical antipsychotic use for patients with bipolar disorder in a medicaid programme

Ying Qiu, Alex Fu (), Gordon Liu and Dale Christensen

Applied Health Economics and Health Policy, 2010, vol. 8, issue 3, 167-177

Abstract: From a third-party payer perspective, atypical antipsychotic mono-therapy generated higher drug costs but lower medical care costs, resulting in equivalent total healthcare costs over a 1-year period. Copyright Adis Data Information BV 2010

Date: 2010
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.2165/11318830-000000000-00000 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:aphecp:v:8:y:2010:i:3:p:167-177

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40258

DOI: 10.2165/11318830-000000000-00000

Access Statistics for this article

Applied Health Economics and Health Policy is currently edited by Timothy Wrightson

More articles in Applied Health Economics and Health Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().